IcoSema was associated with significantly improved body weight and glycemic control among patients with inadequately controlled type 2 diabetes.

A Lancet study projects a surge in liver cancer cases, reaching 1.52 million by 2050, primarily driven by obesity. Deaths are ...

MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.